Barclays Upgrades Ionis Pharmaceuticals (IONS) Stock, Raises PT
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
Posts Tagged ‘NASDAQ:IONS’
11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds
As per the US Bank, the healthcare in the US exhibits a large and intricate ecosystem, which is characterized by size, complexity, and influence on the broader national economy...
First Patient Dosed In Phase 3 REVEAL Study Of ION582 For Angelman Syndrome
Ionis Pharmaceuticals, Inc.
11 Best Genomics Stocks to Buy According to Hedge Funds
Genomics is the study of genes and how they operate.
Ionis (IONS) Announces Leadership Transition as R&D Veteran Richard Geary Prepares to Retire
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is one of the 10 biotech stocks screaming a buy.
10 Biotech Stocks Screaming a Buy
The biotech sector has underperformed the overall market.
Billionaire Glenn Russell Dubin’s 10 Stock Picks with Huge Upside Potential
Glenn Russell Dubin is one of the industry's most experienced hedge fund managers, best known as the co-founder of Highbridge Capital Management, a multi-strategy investment business...
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2025 Earnings Call Transcript
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2025 Earnings Call Transcript April 30, 2025Ionis Pharmaceuticals, Inc. beats earnings expectations.
11 Best Gene Therapy Stocks to Buy According to Analysts
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2024 Earnings Call Transcript
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2024 Earnings Call Transcript February 19, 2025Ionis Pharmaceuticals, Inc. beats earnings expectations.
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US.
10 Top Insider Stock Buys And Sells In January
Ever heard of the “January effect?” In case you haven’t, a “January effect” is considered a phenomenon in the stock market where stock prices, most commonly of small...
10 Mid-Cap Stocks Insiders Are Selling Recently
Why should investors analyze insider trading activity? Insiders, or people in high positions within a company—such as executives and directors—can have crucial insights into...
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2024 Earnings Call Transcript
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2024 Earnings Call Transcript November 6, 2024Ionis Pharmaceuticals, Inc. beats earnings expectations.
10 Stocks with Biggest Upside Potential According to Hedge Funds
The US equities saw a strong move after the September jobs report exceeded the economists’ estimates.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2024 Earnings Call Transcript
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2024 Earnings Call Transcript August 1, 2024Ionis Pharmaceuticals, Inc. beats earnings expectations.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript
Operator: Good morning. And welcome to Ionis' First Quarter 2024 Financial Results Conference Call. As a reminder, this call is being recorded.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2023 Earnings Call Transcript
Ionis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.78. Ionis Pharmaceuticals, Inc.
12 Most Promising Gene Editing Stocks According to Hedge Funds
In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds.
5 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the five best genomics stocks to buy now.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Ionis' Third Quarter 2023 Financial Results Conference Call. As a reminder this call is being recorded.
Top 5 Genomics Companies in the World
In this piece, we will take a look at the top five genomics companies in the world.
16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood’s Portfolio
In this article, we will take a look at the 16 best stocks to buy and hold for the next 15 years according to Cathie Wood's portfolio.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Ionis' Second Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Ionis First Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded.
5 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 5 most promising gene editing stocks according to analysts.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to Ionis Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. . As a reminder, this call is being recorded.
Top 25 Smartest Companies To Buy According To Hedge Funds
In this piece, we will take a look at the top 25 smartest companies to buy according to hedge funds.
10 Stocks to Buy According to Stephen DuBois’ Camber Capital Management
In this article, we discuss 10 Stocks to Buy According to Stephen DuBois' Camber Capital Management.
Should I Buy Ionis Pharmaceuticals, Inc. (IONS)?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Cathie Wood’s ARK Portfolio: Top 15 Losers
In this article, we discuss the 15 biggest losers in the portfolio of Cathie Wood's ARK.
Hedge Funds Are Betting On Ionis Pharmaceuticals, Inc. (IONS)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Are Selling Ionis Pharmaceuticals, Inc. (IONS)
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
10 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 10 best pharmaceutical stocks to buy according to Cathie Wood.
Hedge Funds Dipping Their Toes Into Ionis Pharmaceuticals, Inc. (IONS)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Did Hedge Funds Make The Right Call On Ionis Pharmaceuticals, Inc. (IONS) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Aren’t Crazy About Ionis Pharmaceuticals, Inc. (IONS) Anymore
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Hedge Funds Aren’t Done Buying Ionis Pharmaceuticals, Inc. (IONS)
We hate to say this but, we told you so.
How Did Ionis Pharmaceuticals, Inc. (IONS) Compare Against Top Hedge Fund Stocks in 2019?
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Funds Have Never Been This Bullish On Ionis Pharmaceuticals, Inc. (IONS)
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Is Ionis Pharmaceuticals, Inc. (IONS) A Good Stock To Buy?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Hedge Fund and Insider Trading News: Stanley Druckenmiller, Whitney Tilson, Perceptive Advisors, Bank of New York Mellon Corp (BK), Ionis Pharmaceuticals Inc (IONS), Schlumberger Limited. (SLB), and More
Billionaire hedge fund manager Stanley Druckenmiller on Tuesday warned that the budget deal struck between President Donald Trump and congressional leaders earlier this week will...
Hedge Funds Dropped The Ball On Ionis Pharmaceuticals, Inc. (IONS)?
Is Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
